KM analysis confirms that KIAA1429 elevation is predicted to be a high-risk factor in patients with ACC (p=6.4e-3), DLBC (p=0.02), KIRC (p<0.0001), HNSC (p=5.3e-3), KICH (p=0.014), KIRP (p<0.0001), LIHC (p=7.0e-3), PRAD (p=2.6e-4), UVM (p<0.0001) (Supplementary Figure 2I–2Q). Here, VIRMA is linked to adrenal cortex carcinoma.